Sage Therapeutics, Inc. Proceeds from Common Stock Issued
Sage Therapeutics, Inc. reported Proceeds from Common Stock Issued of $561.28 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-02-24
- Sage Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2019-12-31 was $0.00.
- Sage Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2019-09-30 was $0.00.
- Sage Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2019-06-30 was $0.00.
- Sage Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2019-03-31 was $561.28M, a 11.12% decline year-over-year.
- Sage Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2019 was $561.28M, a 11.12% decline from fiscal 2018.
- Sage Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2018 was $631.49M, a 93.69% increase from fiscal 2017.
- Sage Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2017 was $326.02M, a 1.26% decline from fiscal 2016.
- Sage Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2016 was $330.18M, a 154.53% increase from fiscal 2015.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $561.28M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $561.28M 10-Q · filed 2020-11-05 | $561.28M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $561.28M 10-Q · filed 2020-08-10 | $561.28M derived: sum of 3 quarters · filed 2021-02-24 | $561.28M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $561.28M 10-Q · filed 2020-05-07 | $561.28M derived: sum of 2 quarters · filed 2021-02-24 | $561.28M derived: sum of 3 quarters · filed 2021-02-24 | $561.28M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $0.00 derived: sum of 2 quarters · filed 2021-02-24 | $0.00 derived: sum of 3 quarters · filed 2021-02-24 | $631.49M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $631.49M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $631.49M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $631.49M 10-Q · filed 2019-05-02 | ||||
| 2017-12-31 | $326.02M 10-K · filed 2020-02-27 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $189.18M derived: sum of 2 quarters · filed 2019-02-19 | $189.18M derived: sum of 3 quarters · filed 2019-02-19 | $330.18M 10-K · filed 2019-02-19 | |
| 2016-09-30 | $189.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $189.18M derived: sum of 2 quarters · filed 2017-11-02 | $330.18M 10-Q · filed 2017-11-02 | $330.18M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $141.00M 10-Q · filed 2017-08-03 | $141.00M derived: sum of 3 quarters · filed 2018-02-22 | $141.00M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-03-31 | $141.00M 10-Q · filed 2017-05-10 | $141.00M derived: sum of 2 quarters · filed 2018-02-22 | $141.00M derived: sum of 3 quarters · filed 2018-02-22 | ||
| 2016-01-12 | $140.40M 10-Q · filed 2016-05-06 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $0.00 derived: sum of 2 quarters · filed 2018-02-22 | $129.72M 10-K · filed 2018-02-22 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $129.72M 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | $129.72M 10-Q · filed 2016-08-09 | ||||
| 2015-04-20 | $129.10M 10-K · filed 2016-02-29 | ||||
| 2014-12-31 | $96.25M 10-K · filed 2017-02-24 |